Thomas Yager
AeroLeads people directory · profile

Thomas Yager Email & Phone Number

Sr. Director, Research and Development at ImmuneXpress Inc
Location: Toronto, Ontario, Canada 10 work roles 6 schools
1 work email found @immunexpress.com LinkedIn matched
✓ Verified Jul 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email t****@immunexpress.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Sr. Director, Research and Development
Location
Toronto, Ontario, Canada
Company size

Who is Thomas Yager? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Thomas Yager is listed as Sr. Director, Research and Development at ImmuneXpress Inc, a with 15 employees, based in Toronto, Ontario, Canada. AeroLeads shows a work email signal at immunexpress.com and a matched LinkedIn profile for Thomas Yager.

Thomas Yager previously worked as Sr. Director, Research & Development at Immunexpress Inc and IVD / CDx Consultant at Td Yager Consulting Services. Thomas Yager holds Postdoctoral, Biophysics from King'S College London.

Company email context

Email format at ImmuneXpress Inc

This section adds company-level context without repeating Thomas Yager's masked contact details.

*@immunexpress.com
71% confidence

AeroLeads found 1 current-domain work email signal for Thomas Yager. Compare company email patterns before reaching out.

Profile bio

About Thomas Yager

OBJECTIVEFor the past 20 years I have worked in startup & early-to-mid phase biotech companies, taking various roles in converting discovery-phase assays into robust, validated, manufacturable in vitro diagnostic devices. The challenge: to turn novel biomarkers into clinical diagnostic assays. The approach: a comprehensive approach based on rigorous scientific analysis, design control, preclinical and clinical validation, risk management, and post-approval monitoring.Specialties: SUMMARY OF QUALIFICATIONSRigorous academic training in protein & nucleic acid biochemistry & biophysics, in world-class laboratories. Fifteen years work experience in all aspects of nucleic acid -based IVDs, including biomarker discovery, preclinical & clinical assay validation, design control, pilot & scale-up manufacture, QC & QA, risk analysis, regulatory submissions, post-approval monitoring. I also developed 2 bioassays in zebrafish. Coauthor 45 scientific papers; coinventor 17 patents.

Listed skills include Biotechnology, Fda, Biochemistry, Validation, and 11 others.

Current workplace

Thomas Yager's current company

Company context helps verify the profile and gives searchers a useful next step.

ImmuneXpress Inc
Immunexpress Inc
Sr. Director, Research and Development
Toronto, ON, CA
Employees
15
AeroLeads page
10 roles

Thomas Yager work experience

A career timeline built from the work history available for this profile.

Sr. Director, Research & Development

Greater Seattle Area

Biomarker discovery & initial steps toward validation / commercialization, relating to diagnostic tests for early detection of Sepsis

Ivd / Cdx Consultant

Td Yager Consulting Services

Portland, Oregon Area

Private consulting in the area of IVD / CDx development & validation, design control, risk analysis, software validation. Contracts with ImmuneXpress (Seattle), Pacific Nanoscience (Portland).

Lead Ivd Scientist

Molecularmd

Projects involved IVD assays in the cancer diagnostics area. Worked on three separate PMAs for companion diagnostic tests, which were intended for use with oncology drugs for hematologic and solid tissue tumors. Focus was on requirements specification, design control, risk analysis, analytical & clinical validation, software design and software validation.

Oct 2010 - Oct 2013

Ivd Consultant

Td Yager Consulting Services

Private consulting in the area of IVD Development. Contracts with ArcticDx (Toronto ON), Xagenic (Toronto ON), MolecularMD (Portland OR)

Apr 2010 - Oct 2010

Principal Scientist

In this position I worked on developing genotyping assays (Cystic Fibrosis, CYP 2D6, Ashkenazi Jewish Panel), and pathogen detection assays (respiratory viruses, gastrointestinal pathogens). I was an integral member of teams that successfully obtained FDA clearances for Cystic Fibrosis genotyping (K060627, K083845, K083846), CYP2D6 genotyping (K093420), detection of a panel of respiratory viruses (K063765, K091667), and detection of a panel of GI pathogens (K121454). Responsibilities included… Show more In this position I worked on developing genotyping assays (Cystic Fibrosis, CYP 2D6, Ashkenazi Jewish Panel), and pathogen detection assays (respiratory viruses, gastrointestinal pathogens). I was an integral member of teams that successfully obtained FDA clearances for Cystic Fibrosis genotyping (K060627, K083845, K083846), CYP2D6 genotyping (K093420), detection of a panel of respiratory viruses (K063765, K091667), and detection of a panel of GI pathogens (K121454). Responsibilities included design control, risk analysis, validation studies, statistical analysis. Show less

Feb 2006 - Apr 2010

Director Product Development & Qa

In my QA role, I was responsible for the initial setup of a Quality System according to the ISO-9001 model. I also set up a small pilot manufacturing facility, developed chain-of-custody procedures for sample handling, and conducted internal quality audits. In my Product Development role, I worked on converting discovery phase biomarkers for various diseases (osteoarthritis, bipolar disorder, and colorectal cancer) into RT-PCR based RNA expression assays, and on pre-clinical validation of these… Show more In my QA role, I was responsible for the initial setup of a Quality System according to the ISO-9001 model. I also set up a small pilot manufacturing facility, developed chain-of-custody procedures for sample handling, and conducted internal quality audits. In my Product Development role, I worked on converting discovery phase biomarkers for various diseases (osteoarthritis, bipolar disorder, and colorectal cancer) into RT-PCR based RNA expression assays, and on pre-clinical validation of these assays. Show less

Mar 2003 - Feb 2006

Director, R&D

Visible Genetics

In 1995 I became a consultant for Visible Genetics (Toronto) and continued in this capacity until I took full-time employment there in 1998, where I held positions of increasing responsibility (Senior Scientist, Development Manager, Director of Chemistry R&D). In 2001, Visible Genetics achieved FDA approval of its HIV-1 Genotyping Kit (BK020005), based in part on the work of my R&D Group. I next accepted a position as Director of Technology Transfer at Visible Genetics (Atlanta), where… Show more In 1995 I became a consultant for Visible Genetics (Toronto) and continued in this capacity until I took full-time employment there in 1998, where I held positions of increasing responsibility (Senior Scientist, Development Manager, Director of Chemistry R&D). In 2001, Visible Genetics achieved FDA approval of its HIV-1 Genotyping Kit (BK020005), based in part on the work of my R&D Group. I next accepted a position as Director of Technology Transfer at Visible Genetics (Atlanta), where I worked for 1 year on pilot-scale manufacturing, troubleshooting, and process validation for infectious disease assays (HIV-1, HBV) and genotyping assays (HLA). Show less

Sep 1998 - Mar 2003

Scientist

Located in Toronto. Principal Investigator in grants-funded research program, to study activation of cell-cycle checkpoints and apoptosis in early zebrafish embryo, as a model system for very early cancers. Responsibilities included writing grant proposals, maintaining an independent research program, writing peer-reviewed scientific papers, giving presentations at conferences, and supervising graduate and undergraduate students. Successfully developed 2 bioassays for genotoxic substances… Show more Located in Toronto. Principal Investigator in grants-funded research program, to study activation of cell-cycle checkpoints and apoptosis in early zebrafish embryo, as a model system for very early cancers. Responsibilities included writing grant proposals, maintaining an independent research program, writing peer-reviewed scientific papers, giving presentations at conferences, and supervising graduate and undergraduate students. Successfully developed 2 bioassays for genotoxic substances, using flattened whole mounts of zebrafish embryos. Show less

Mar 1993 - Sep 1998

Scientist

Nsf Center For Molecular Biotechnology (Caltech)

This NSF-funded center at Caltech, directed by Leroy Hood, was designed to be an interface between academia and industry. In this position I worked on technology for rapid, semi-automated genotyping by the oligonucleotide ligation assay (OLA). This work was later extended at Visible Genetics, to a patented technology (SLAM) for mutation scanning by multiple oligonucleotide ligation.

Sep 1991 - Mar 1993
6 education records

Thomas Yager education

Postdoctoral, Biophysics

Postdoctoral study in the laboratories of Hannah Gould and James Allan, where I worked on structure / function of histone H5 and its.

Postdoctoral, Biophysics

Postdoctoral work in laboratory of Henryk Eisenberg, where I worked on developing a model system to simulate protein-nucleic acid.

Postdoctoral, Molecular Biology

Postdoc in the laboratory of Peter H. von Hippel, where I worked on fundamental mechanisms of transcription (transcription bubble.

Phd, Biochemistry & Biophysics

PhD student in the laboratory of Kensal E van Holde, where I worked on salt-induced instabilities in nucleosomes and chromatin.

Ms, Developmental Biology

Graduate work in developmental biology under Dennis Barrett, using sea urchin as model system to study precisely timed developmental event.

Ba, Biology

Activities and Societies: phi beta kappa Bachelor's level study in biology, chemistry, mathematics

FAQ

Frequently asked questions about Thomas Yager

Quick answers generated from the profile data available on this page.

What company does Thomas Yager work for?

Thomas Yager works for ImmuneXpress Inc.

What is Thomas Yager's role at ImmuneXpress Inc?

Thomas Yager is listed as Sr. Director, Research and Development at ImmuneXpress Inc.

What is Thomas Yager's email address?

AeroLeads has found 1 work email signal at @immunexpress.com for Thomas Yager at ImmuneXpress Inc.

Where is Thomas Yager based?

Thomas Yager is based in Toronto, Ontario, Canada while working with ImmuneXpress Inc.

What companies has Thomas Yager worked for?

Thomas Yager has worked for Immunexpress Inc, Td Yager Consulting Services, Molecularmd, Luminex Molecular Diagnostics, and Genenews Corporation.

How can I contact Thomas Yager?

You can use AeroLeads to view verified contact signals for Thomas Yager at ImmuneXpress Inc, including work email, phone, and LinkedIn data when available.

What schools did Thomas Yager attend?

Thomas Yager holds Postdoctoral, Biophysics from King'S College London.

What skills is Thomas Yager known for?

Thomas Yager is listed with skills including Biotechnology, Fda, Biochemistry, Validation, R&D, Medical Devices, Molecular Biology, and Design Control.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Thomas Yager you were looking for.

View similar profiles